日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The p53 R181C mutation accumulates through impaired deacetylation by Sirt1 and facilitates tumor development.

p53 R181C 突变通过 Sirt1 的去乙酰化作用受损而积累,并促进肿瘤发展。

Wang Erli, Cao Liangzi, Guo Wendong, Dong Xiang, Zhang Wanying, Zhang Xiaowen, Wang Zhuo, Chen Xia, Li Aicun, Zou Yu, Li Shikun, Chen Kedian, Su Han, Cao Sunrun, Du Ning, Wang Pingyuan, Hwang Paul M, Liu Xiangsheng, Song Xiaoyu, Xu Hongde, Liu Jingwei, Cao Liu

An aptamer-drug conjugate for promising cancer therapy with comprehensive evaluation from rodents to non-human primates.

一种用于癌症治疗的适体-药物偶联物,已从啮齿动物到非人灵长类动物进行了全面评估

Su Minhui, Liu Yuan, Lin Hongxin, Wang Xiaoxing, Ying Danxia, Zhang Lizhuan, Yang Cai, Jiang Mengyuan, Xu Lujuan, Wang Xie, Sun Yang, Xu Haiyan, Zhang Ziwen, Wang Xiaojia, Fu Ting, Xie Sitao, He Jiaxuan, Liu Xiangsheng, Tan Weihong

Transcytotic transportation of size-controlled nanocarriers into dystrophic skeletal muscle leads to therapeutic outcome in mice.

将尺寸可控的纳米载体通过胞吞作用运输到营养不良的骨骼肌中,可对小鼠产生治疗效果。

Liu Xiangsheng, Hicks Michael R, Feng Zhenhan, Jiang Jinhong, Li Yuting, Young Courtney S, Zhang Tianyu, Saleh Kholoud, Emami Michael R, Liu Yanyan, Qin Mengmeng, Li Jiulong, Zheng Yile, Yang Honghong, Spencer Melissa J, Pyle April D, Meng Huan

Intraperitoneal programming of tailored CAR macrophages via mRNA lipid nanoparticle to boost cancer immunotherapy.

通过mRNA脂质纳米颗粒对定制CAR巨噬细胞进行腹腔内编程,以增强癌症免疫疗法。

Gu Kedan, Liang Ting, Hu Luting, Zhao Yifan, Ying Weiyang, Zhang Mengke, Chen Yashuang, Liang Benmeng, Lin Xinrui, Zhang Yanqi, Wu Hongyu, Wang Meng, Zhu Yuping, Wang Wenxi, Zhang Yu, Zuo Chao, Du Zhen, Zhang Penghui, Song Jia, Li Liwen, Liu Xiangsheng, Xie Sitao, Tan Weihong

Sortilin-Mediated Rapid, Precise and Sustained Degradation of Membrane Proteins via mRNA-Encoded Lysosome-Targeting Chimera.

通过 mRNA 编码的溶酶体靶向嵌合体介导 Sortilin 介导的膜蛋白的快速、精确和持续降解

Chang Xin, Qiu Xinyu, Tong Xiaoning, Gan Shaoju, Yi Weicheng, Xie Sitao, Liu Xiangsheng, Zuo Chao, Tan Weihong

LRPPRC confers enhanced oxidative phosphorylation metabolism in triple-negative breast cancer and represents a therapeutic target.

LRPPRC 可增强三阴性乳腺癌的氧化磷酸化代谢,并可作为治疗靶点

Xue Qiqi, Wang Wenxi, Liu Jie, Wang Dachi, Zhang Tianyu, Shen Tingting, Liu Xiangsheng, Wang Xiaojia, Shao Xiying, Zhou Wei, Fang Xiaohong

Hyaluronic acid-based dual network hydrogel with sustained release of platelet-rich plasma as a diabetic wound dressing

透明质酸基双网络水凝胶缓释富血小板血浆作为糖尿病伤口敷料

Jie Zhou, Yufei Liu, Xiangsheng Liu, Jinpeng Wan, Shuyu Zuo, Tengwu Pan, Yanyu Liu, Feifan Sun, Minli Gao, Xinyi Yu, Weihong Zhou, Jun Xu, Zhenyu Zhou, Shufang Wang

Orientational Nanoconjugation with Gold Endows Marked Antimicrobial Potential and Drugability of Ultrashort Dipeptides

金纳米取向偶联赋予超短二肽显著的抗菌潜力和成药性

Zhang, Zhiye; Chen, Yaoyao; Gao, Jinai; Yang, Min; Zhang, Dengdeng; Wang, Le; Zhang, Tianyu; Cao, Qiqi; Mwangi, James; He, Chenglu; Li, Ya; Liu, Xiangsheng; Jiang, Xingyu; Kamau, Peter Muiruri; Lai, Ren

Network-Based Method to Investigate the Promoted Cell Apoptosis Mechanisms of Oridonin in OSCC through the RNA-Transcriptome

基于网络的方法通过 RNA 转录组研究冬凌草甲素在口腔鳞状细胞癌中促进细胞凋亡的机制

Guohui Wu, Yusheng Guo, Yang Liu, Xiangsheng Cai, Tanggang Deng, Tianchu Pei, Long Huang, Kai Chen, Xuan Pan

Multifunctional Lipid Bilayer Nanocarriers for Cancer Immunotherapy in Heterogeneous Tumor Microenvironments, Combining Immunogenic Cell Death Stimuli with Immune Modulatory Drugs

用于异质性肿瘤微环境中癌症免疫治疗的多功能脂质双层纳米载体,结合免疫原性细胞死亡刺激和免疫调节药物

Nel, André E; Mei, Kuo-Ching; Liao, Yu-Pei; Liu, Xiangsheng